Cargando…
Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice
Sodium glucose cotransporter-2 (SGLT2) inhibitors inhibit the development of diabetic nephropathy (DN). We determined whether changes in perirenal fat (PRAT) by a SGLT2 inhibitor ipragliflozin (Ipra) contribute to the suppression of DN development. High-fat diet (HFD)-fed mice were used as a DN mode...
Autores principales: | Okuma, Hideyuki, Mori, Kentaro, Nakamura, Suguru, Sekine, Tetsuo, Ogawa, Yoshihiro, Tsuchiya, Kyoichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304702/ https://www.ncbi.nlm.nih.gov/pubmed/34298949 http://dx.doi.org/10.3390/ijms22147329 |
Ejemplares similares
-
Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice
por: Mori, Kentaro, et al.
Publicado: (2019) -
Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals
por: Nakamura, Suguru, et al.
Publicado: (2021) -
Melanocortin-4 receptor in macrophages attenuated angiotensin II-induced abdominal aortic aneurysm in mice
por: Mori, Kentaro, et al.
Publicado: (2023) -
A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition
por: Miyachi, Yasutaka, et al.
Publicado: (2018) -
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
por: Komiya, Chikara, et al.
Publicado: (2016)